What Causes Functional Neurological Disorder? Mechanisms, Risk, and Triggers
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Functional neurological disorder (FND) develops when networks involved in movement, sensation, attention, and the experience of control over actions function in an altered way. Its exact cause is still being investigated. Current evidence supports several interacting pathways involving brain-network function, symptom expectations, physical illness or injury, stress-system responses, and individual vulnerability. No single factor explains every case. A 2026 review of mechanisms and vulnerabilities and a 2025 systematic review of risk and triggering factors describe this multifactorial picture.
Symptoms such as weakness, tremor, episodes resembling epileptic seizures, changes in walking, and altered sensation are genuinely experienced and may cause substantial disability. FND is diagnosed through a neurological history and examination that identify positive signs of altered function, interpreted alongside appropriate assessment for other conditions. A stressful event or traumatic history is neither necessary nor sufficient for diagnosis. Aybek and Perez's clinical review explains the contemporary rule-in approach.
This article examines what scientists mean by a cause of FND; how predictive processing, attention, agency, and brain networks might contribute; what research establishes about trauma, medical events, and psychiatric conditions; why triggers differ across people; and what these findings mean for assessment, treatment, and recovery. Research on mechanisms is active, and explanations that sound convincing still need direct experimental validation.
What does it mean to ask what causes FND?
A cause is a factor or process that brings about an outcome. In FND, researchers distinguish mechanisms that could generate symptoms from vulnerabilities that make symptoms more likely, events that occur near their onset, and influences that maintain symptoms after onset. These are related questions, but evidence for one does not automatically establish the others.
A mechanism describes how an alteration in neural processing could produce an involuntary symptom. A risk factor is associated with a higher probability of FND across a studied population; it cannot determine whether an individual will develop it. A precipitating factor or trigger is an event temporally linked to the start or worsening of symptoms. A perpetuating factor may contribute to ongoing disability or recurrence. A prognostic factor concerns later outcomes. Mavroudis and colleagues' systematic review uses this framework across several FND presentations, while a separate 2025 systematic review of prognostic indicators shows why evidence about future outcomes deserves its own evaluation.
An example illustrates the distinction. A person may develop altered walking after a painful ankle injury. The injury is a plausible precipitant because the timing is clear. Whether pain, changed movement expectations, heightened attention, a specific brain-network process, or a combination generated the persistent walking pattern must be examined rather than assumed. The patient may have no identifiable psychological precipitant. Equally, a person who has experienced severe stress can develop neurological symptoms from many causes; the stress itself cannot determine the diagnosis.
What happens in the nervous system in FND?
FND is increasingly studied as a disorder of neural functioning across interacting systems rather than a single damaged brain location. Research examines motor planning, sensory integration, body representation, attention, salience, emotion, and the sense that one's actions are self-generated. Studies using functional MRI, behavioral tasks, and physiological measurements have reported differences at the group level. They have not established an individual diagnostic brain scan or a universal neural signature. Dworetzky and Baslet (2025) summarize the clinical implications, and Prudente and colleagues (2026) review current mechanistic models.
The distinction between function and structure requires care. Some people have FND with structurally normal routine investigations; others also have migraine, epilepsy, brain injury, or another medical disorder. Researchers have even reported structural or microstructural group differences in some imaging studies. A functional diagnosis identifies a characteristic clinical pattern; it does not depend on proving that every brain structure is normal. Standard structural MRI also cannot directly measure all the neural operations proposed in FND models.
Predictive processing: how the brain uses expectations and sensory input
The brain continually integrates incoming information with prior expectations to estimate what the body is doing and how an intended movement should unfold. Predictive-processing models propose that, under some circumstances, strongly weighted expectations or prior learned patterns influence perception and movement more than incoming corrective signals. Researchers call the balance between expectations and incoming evidence precision weighting. This is an active explanatory framework, not a demonstrated universal molecular cause of FND. Jungilligens and Perez's review sets out the model in relation to agency, interoception, symptom expectations, and motor control.
Consider ordinary walking. Much of the movement runs automatically, with sensory feedback continuously updating posture, balance, and the next step. The hypothesis is that certain FND symptoms may involve altered weighting of expectations and feedback, so a pattern of impaired movement is produced or maintained involuntarily even when parts of the motor system can still support different movement under other conditions. This interpretation can help explain variability between automatic and deliberately attempted actions, but it does not prove a particular mechanism in a specific patient.
A September 2026 neurocomputational account by Putica proposes how stress-related neural modulation might increase the influence of certain sensorimotor predictions. The author also specifies experimental predictions that could be disproved. Its status is a newly published theoretical account, not a validated diagnostic model or clinical test. This distinction matters whenever predictive processing is presented as a complete answer to why FND develops.
Attention, bodily monitoring, and salience
Attention changes how strongly the brain processes sensations and motor actions. In ordinary experience, a movement may feel less smooth when every detail is consciously monitored. FND research investigates whether symptom-focused attention can disrupt patterns that ordinarily run more automatically, and why distraction or a change of task may sometimes alter the observable symptom. Salience networks involved in selecting important internal and external information are among the candidate systems. Aybek and Perez (2022) and Dworetzky and Baslet (2025) discuss these observations.
Changes with attention are clinically meaningful in certain contexts, such as variable tremor or functional weakness. They do not demonstrate conscious control, simulation, or deliberate symptom production. A reflexive or automatic change in performance is different from choosing to create a disability. Nor does distractibility by itself diagnose FND: a neurologist must interpret a validated positive sign in the context of a specific symptom and evaluate other plausible causes.
Interoception, the nervous system's processing of internal bodily signals, is another area of research. Internal sensations may influence threat perception, arousal, and expectations about bodily control. A person may notice palpitations, breathlessness, dizziness, or unusual sensations around symptom onset, but similar experiences occur with anxiety, autonomic disorders, migraine, medication effects, and numerous medical conditions. The relationship requires assessment rather than a general assumption of FND. For background on this broader mechanism, see Anxiety and Interoception: Why Body Sensations Can Become Threat Signals.
Sense of agency and motor control
Sense of agency means the experience that an action is one's own and under one's control. People with certain functional motor symptoms may report that a movement, tremor, or loss of movement happens outside their intentions. Research into motor preparation and awareness of action asks whether a mismatch between motor predictions and feedback contributes to that experience. Prudente and colleagues (2026) identify agency and sensorimotor integration as major research domains.
Some functional movement signs reveal a discrepancy between an attempted voluntary action and movement occurring automatically in a different task. This offers a clinically observable basis for diagnosis and, potentially, a target for rehabilitation. It should never be reinterpreted as proof that the patient can simply decide to stop having symptoms. The ability to produce a movement under one condition may coexist with a genuine inability to reliably produce it under another.
Emotion, arousal, and stress-response systems
Brain systems involved in detecting threat, regulating arousal, and processing emotion interact with motor and sensory networks. Researchers have investigated whether heightened arousal changes motor inhibition, attentional priorities, bodily predictions, or symptom expression in susceptible individuals. The mechanisms vary across studies and FND phenotypes; a universal causal sequence has not been established. The 2026 review by Prudente and colleagues and the 2025 practical review by Dworetzky and Baslet place these processes within a wider neurobiological and clinical framework.
A stress response can accompany physical illness, pain, sleep loss, intense emotion, or fear. Stress can contribute to symptoms without being consciously recognized, and FND can also occur without a relevant stressor. Measuring stress or anxiety in an individual would not establish the cause of their neurological symptoms. The independent diagnostic evaluation remains essential.
What brain imaging can and cannot show
Functional imaging studies have found group-level alterations in networks associated with sensory and motor processing, agency, emotional salience, and attention. These findings are important because they make proposed mechanisms testable. However, small samples, mixed FND subtypes, differences in task design, psychiatric and medication confounders, and variable replication limit interpretation. A 2024 neuroimaging study of BOLD-signal variability explored possible state or prognostic markers; such exploratory findings should not be promoted as established diagnostic biomarkers.
A routine clinical MRI serves a different purpose from research functional MRI. It may help evaluate an alternative or coexisting neurological condition, depending on the symptoms and examination. A normal scan is not positive proof of FND. A research finding about average connectivity cannot demonstrate that a particular symptom was psychologically caused or establish whether any one person will recover.
Risk factors: what makes FND more likely?
Epidemiological associations help identify possible vulnerabilities. They are influenced by study populations, referral patterns, how subtypes are defined, and which comparison groups are used. Many published studies come from specialty clinics, so their findings may not generalize to every person with FND. The 2025 subtype-spanning systematic review found a heterogeneous evidence base and emphasized differences across clinical presentations.
Prior neurological conditions and bodily symptoms
Migraine, epilepsy, some movement disorders, pain, and fatigue can coexist with FND and sometimes precede its onset. They may supply a context of altered sensory experience, disrupted activity, or repeated attention to physical symptoms. Physical illness can also produce symptoms that resemble an FND presentation, so the order and nature of events must be carefully reconstructed. The BMJ clinical review discusses co-occurring neurological conditions and the importance of specific positive findings.
FND and a confirmed neurological diagnosis can occur in the same patient. For instance, someone may have both epileptic and functional seizures, or migraine alongside functional weakness. One diagnosis should not erase another. The American Academy of Neurology's 2026 functional-seizure guideline specifically recommends evaluation for co-occurring epilepsy.
Anxiety, depression, PTSD, and dissociative symptoms
Anxiety disorders, depression, post-traumatic stress disorder, and dissociative symptoms occur frequently in studied FND populations. Some of these conditions may precede FND, while others can arise after disabling symptoms begin. Their presence can influence distress, treatment needs, and outcomes without proving the origin of the neurological syndrome. The 2025 systematic review describes these comorbidities and cautions that profiles differ by subtype.
Anxiety may increase vigilance to bodily sensations; depression may affect sleep, energy, and rehabilitation engagement; PTSD may be relevant to an individual person's triggers. Each requires its own assessment and, when indicated, care. FND cannot be equated with an anxiety disorder or PTSD. For a related but separately owned topic, see Physical Symptoms of PTSD: Stress Responses and Medical Assessment.
Adversity and traumatic experiences
Adverse childhood experiences and stressful life events are more common in some groups with FND than in control groups. A 2018 systematic review and meta-analysis by Ludwig and colleagues found elevated associations with childhood maltreatment and events preceding symptom onset. It also documented substantial heterogeneity, methodological limitations, and people with FND who reported no severe stressor. Associations were generally stronger in some functional-seizure samples than in other presentations.
The clinical conclusion is precise: trauma can be relevant to vulnerability or symptom development in some patients, and it is not a required or sufficient cause. A person does not need to identify abuse, psychological conflict, or a stressful life event to receive a valid FND diagnosis. Asking about trauma may support a patient's care when done sensitively and for a clinical purpose; treating the disclosure of trauma as proof of FND, or its absence as disproof, is inappropriate.
Sex, gender, age, and study-population differences
Some clinical samples contain more women and girls than men and boys, but sex distributions differ by syndrome, setting, ascertainment, and age group. Observed differences do not establish a simple sex-specific biological cause. Similarly, rates of documented childhood adversity may depend on which questions were asked and whether participants felt safe answering them. Finkelstein and colleagues' 2025 systematic review of FND incidence and prevalence illustrates the importance of case definitions and populations when interpreting frequency data.
Proposed genetic, developmental, or epigenetic influences remain research topics. A review may discuss possible biological vulnerability without demonstrating a validated hereditary pattern or a predictive genetic test for FND. In everyday clinical practice, family history, demographic characteristics, and psychiatric history cannot substitute for the neurological examination.
Triggers: what can happen before symptoms begin?
A precipitating event is often the part of a person's story that feels most concrete. FND symptoms may develop suddenly or gradually. They may begin around a physical event, a highly stressful period, a pre-existing neurological symptom, or an apparently ordinary day with no identifiable trigger. Describing an event as a trigger requires attention to chronology, competing diagnoses, and the possibility of coincidence.
Physical injury, surgery, illness, and infection
Injury, surgery, acute illness, and infection have been reported before the onset of certain functional symptoms. In a 2014 clinical cohort study of physical precipitants in functional movement disorders, many participants described a preceding physical event, including injury or infection. That study was small and based on a referred cohort; it does not show that these events cause FND at the same rate in the general population.
A physical event may initially cause genuine pain, impaired movement, altered sensation, or fear. Once the original medical problem has improved, a functional symptom pattern may sometimes persist. Alternatively, symptoms may reflect continuing injury, complications, a second medical disorder, or both. These alternatives require appropriate medical review. A recent infection followed by weakness, for example, deserves evaluation for relevant neurological and systemic causes before anyone attributes the weakness to FND.
Migraine, epilepsy, and other neurological events
A migraine attack, seizure, transient loss of consciousness, or period of severe dizziness may occur close to symptom onset. These events may alter sensory experience, movement, autonomic state, and a person's expectations of what will happen next. Functional symptoms can also coexist with the neurological disease itself. Aybek and Perez (2022) emphasize individualized neurological assessment.
If a person has seizure-like events, the cause cannot be decided from a written description, emotional context, or a single normal routine EEG. Specialist history, witness accounts, videos when appropriate, and video EEG when feasible may be needed to distinguish functional seizures from epilepsy and identify both where they coexist. The AAN guideline provides current recommendations.
Acute fear, stress, interpersonal events, and prolonged strain
Bereavement, conflict, sustained caregiving demands, high-pressure work, threats to safety, or traumatic experiences have been described before onset in some people. The relationship may involve changes in arousal, sleep, attention, bodily sensations, or coping patterns. Observational reports cannot by themselves establish a specific neural pathway from the life event to the symptom. Ludwig and colleagues' meta-analysis supports an association with stressors, and Mavroudis and colleagues (2025) summarize precipitating factors across studies.
A patient who says, "Nothing stressful happened," is providing clinically relevant information. The task is to assess the symptoms and help the person, not to reconstruct a hidden trauma narrative. Psychotherapeutic exploration can be useful when requested or clinically appropriate, but finding a psychologically meaningful story is not a prerequisite for a legitimate diagnosis.
Sleep disruption, fatigue, pain, and sensory overload
Poor sleep, fatigue, pain, and high sensory demand can affect concentration, movement efficiency, physiological arousal, and day-to-day symptom variability. Clinicians often consider them in individualized symptom formulations and rehabilitation plans. Their causal role in initiating FND is less securely established than some discussions imply; they may act as triggers, coexisting problems, or consequences of disability. Dworetzky and Baslet's practical review supports identifying and managing these factors without claiming that every episode is caused by them.
Why no trigger may be identifiable
A person may develop FND without remembering any event at onset or without having an identifiable precipitant. The 2018 meta-analysis found that patients without identified severe stressors were present across studies that explicitly assessed this issue. This is compatible with a multifactorial condition in which clinical presentation may emerge through pathways not yet fully understood. Neither the patient nor the clinician needs to produce a definitive origin story before working on diagnosis and care.
What can maintain or worsen functional symptoms over time?
The factors that sustain disability may differ from those that preceded onset. Avoidance of movement because of repeated falls, pain, deconditioning, fear of provoking episodes, disrupted sleep, and difficulties accessing specialized care can become relevant. Negative encounters in which symptoms are dismissed may damage trust and postpone effective rehabilitation. The 2025 systematic review of risk, precipitating, and perpetuating factors describes several such influences, although many underlying studies remain observational.
Symptom-directed attention or strong expectations about failure may contribute to certain ongoing motor patterns within predictive-processing accounts. This is a hypothesis that can guide therapy design and research, not a moral judgment about a patient's beliefs or a claim that positive thinking alone can reverse symptoms. Practical supports, workplace accommodations, treatment of co-occurring illness, and pacing may also affect participation. Distinguishing symptom generation from the broader disability surrounding it leads to more realistic treatment goals.
There is also an important evidentiary caution: an association between avoidance, fear, disability, and symptom severity does not establish which came first. Patients often avoid activities because they have already fallen, experienced painful symptoms, or received inadequate safety advice. Clinical care should investigate the real obstacles to participation instead of assuming that a behavior caused the illness.
Do the causes differ between FND subtypes?
FND includes functional weakness, tremor and other movement symptoms, gait disturbances, sensory symptoms, functional seizures, and some cognitive presentations. These share aspects of clinical reasoning but are heterogeneous. It is premature to assume identical etiological mechanisms across every subtype. The 2025 systematic review across clinical subtypes identified both shared and subtype-associated factors.
Functional motor presentations often raise questions about motor planning, attention, agency, pain, and precipitating physical events. Functional seizures involve episodes whose event characteristics require neurological evaluation and often different treatment evidence. Functional cognitive complaints raise questions about attention, memory confidence, fatigue, and competing neurological or psychiatric explanations. A 2025 meta-analysis of neurocognitive performance in FND found mixed objective findings and substantial confounding, underlining why cognitive mechanisms require distinct study.
The fact that a theory fits one clinical phenotype does not establish that it explains another. Treatment recommendations for functional seizures, for example, should not automatically be generalized to functional tremor or weakness. The 2026 AAN guideline is specifically about functional seizures, whereas rehabilitation recommendations for functional motor symptoms draw on a different evidence base.
Are trauma or psychological conflict necessary for FND?
No. Modern diagnostic criteria do not require proof of psychological conflict, trauma exposure, or a recent stressful event. The older label conversion disorder reflects a historical explanatory model that should not be imposed as an etiological fact on contemporary patients. The DSM-5-TR chapter from the American Psychiatric Association and Aybek and Perez's review place diagnostic attention on symptoms and clinical findings rather than demonstrating a psychological origin.
Some people with FND have PTSD; many do not. Some have substantial anxiety or depression; others do not meet criteria for either disorder. A history of adversity deserves sensitive recognition and may influence treatment choices, but FND is not a retrospective test for whether someone was traumatized. Likewise, no clinician can infer intentional deception from symptoms fluctuating or improving during distraction.
For the historical terminology and its relationship to modern clinical concepts, see the separate English Hub article Conversion Neurosis: Historical Meaning and Functional Neurological Symptom Disorder. The current article's subject is modern etiological evidence.
Is FND caused by brain damage, a chemical imbalance, or genetics?
There is currently no established single brain lesion, neurotransmitter deficiency, blood test, or genetic variant that explains FND in every patient. Researchers have reported group-level functional and structural imaging differences and proposed genetic or epigenetic vulnerabilities, but these observations have not yielded a clinically validated individual causal test. Prudente and colleagues (2026) review the developing models, and Dworetzky and Baslet (2025) describe the limits of clinical testing.
The term functional refers to the way the disorder is clinically expressed in nervous-system operation. It is not a guarantee that a person's entire brain structure is normal, and it is not a reason to ignore a known injury, migraine, seizure disorder, or another diagnosis. Medical disorders and FND can coexist. Research descriptions of neurochemicals or stress hormones remain explanatory hypotheses unless studies establish a specific mechanism and its clinical relevance.
How do clinicians distinguish FND from other neurological and medical conditions?
Diagnosing FND begins with the clinical history, the type of symptom, and a neurological examination. Depending on the presentation, a neurologist may identify internally inconsistent performance, a pattern of movement changing with specific tasks, or a recognized positive sign such as Hoover's sign for certain types of functional limb weakness or entrainment for functional tremor. Such findings are interpreted in context, including examination of other neurological systems and indicated tests. The 2025 practice review explains these principles.
A positive sign is not an internet self-test. Validity and interpretation depend on the procedure, examiner, population, and differential diagnosis. Normal structural imaging, no abnormal result from one laboratory test, or the presence of anxiety cannot establish FND alone. Appropriate evaluation may consider stroke, multiple sclerosis, epilepsy, migraine, vestibular and autonomic disorders, movement disorders, medication effects, metabolic illness, and other possibilities according to clinical findings. A prior FND diagnosis must not automatically explain a newly developed symptom.
Functional seizures need special consideration because epileptic and functional seizures can coexist. Video EEG recording of a typical event may be important when feasible, along with history and event characteristics. The AAN clinical practice guideline provides recommendations for assessing epilepsy alongside functional seizures. A related English Hub differential overview is Panic Attack vs Seizure: Symptoms, Awareness, and Medical Assessment.
An urgent evaluation is appropriate for a new one-sided weakness or facial droop, sudden speech loss, a first seizure-like episode, serious injury during an event, prolonged impaired consciousness, rapidly worsening neurological function, or other acute symptoms suggesting a neurological or medical emergency. Time-sensitive conditions, especially stroke, require emergency services rather than interpreting the event through an existing FND label.
What does the causal research mean for treatment?
Treatment targets the person's actual symptoms, functioning, safety, and coexisting conditions. Understanding possible mechanisms can help clinicians explain why rehabilitation may change functional patterns, why specialist movement retraining may focus on automatic rather than effortful control, and why psychotherapy may help some people address distress, arousal, avoidance, or symptom-related beliefs. An intervention's benefit does not prove the proposed cause: multiple mechanisms can produce the same therapeutic response. Dworetzky and Baslet (2025) describe coordinated neurological and rehabilitative management.
For functional motor symptoms, appropriately trained physical and occupational therapists may work with movement retraining, graded function, activity participation, and treatment of relevant pain or fatigue. For functional seizures, assessment of epilepsy and individualized psychological care matter; medication decisions require the treating clinician. The 2026 AAN guideline advises against antiseizure medication solely for functional seizures when epilepsy and other indications are absent, and recommends clinician-supervised medication management. Patients should never independently stop prescribed antiseizure medication on the strength of reading about FND.
Trauma-focused treatment can be appropriate when a separate trauma-related disorder or clinically relevant traumatic experiences are present and the person wishes to address them. It is not a universal prerequisite for FND care. Equally, psychiatric treatment alone should not be treated as a substitute for neurological assessment or physical rehabilitation when these are indicated.
Recovery varies. A 2025 systematic review and meta-analysis of treatment outcomes and symptom duration found that longer symptom duration was associated with more limited improvement in some motor or physical quality-of-life outcomes, while meaningful improvements remained possible across symptom durations. Those are group-level findings, not a timetable for an individual's recovery. A separate 2025 prognostic systematic review found limitations in the strength and consistency of many proposed psychological predictors.
FND in children and adolescents: special considerations
Children and adolescents may develop functional neurological symptoms in the context of illness, injuries, school stress, developmental changes, and family circumstances, with or without a clear precipitant. Adults should consider the child's developmental stage, communication needs, school participation, peer relationships, sleep, family resources, and the effects of repeated medical appointments. Clinicians must also provide an age-appropriate neurological and pediatric assessment for competing and coexisting conditions.
The Canadian Paediatric Society's 2024 clinical guidance recommends validating the child's experience, communicating a clear diagnostic formulation, coordinating professionals, supporting rehabilitation and return to daily activities, and reassessing evolving symptoms. Family involvement should support the child rather than searching for someone to blame. The child or parent should not be told that school pressure, family conflict, or stress necessarily caused the symptoms.
What researchers still need to establish
Three major gaps remain. First, many studies identify associations but do not follow sufficiently diverse people prospectively from before symptom onset. This makes it difficult to determine which apparent vulnerabilities are causal, which accompany other conditions, and which arise after disability. Second, neuroimaging and behavioral studies often recruit mixed presentations and small samples, limiting reproducibility and the identification of subtype-specific mechanisms. Third, mechanistic theories require experiments capable of distinguishing one model from its competitors. Prudente and colleagues (2026), Mavroudis and colleagues (2025), and Putica (2026) illustrate these different stages of evidence.
Validated individual biomarkers, genetic risk predictions, universal causal pathways, and reliable methods for assigning one person's symptoms to a particular past event are not yet available. Research that eventually identifies mechanisms may improve targeted rehabilitation and stratified treatment, but the present scientific uncertainty should be represented clearly in patient information. FND can be diagnosed and treated using current clinical standards while the underlying causal science continues to develop.
Practical questions to discuss with a clinician
A productive clinical conversation can ask which specific examination findings support the FND diagnosis; which other conditions have been considered or might coexist; what changes should prompt reassessment; which treatment is suitable for the actual symptom subtype; how pain, sleep, fatigue, and mental health concerns will be addressed; and what functional goals matter most to the patient. If a symptom began after an injury or medical event, a timeline including tests, medications, and recovery from the original illness can clarify the clinical formulation.
Patients can describe what makes symptoms better or worse without needing to prove a psychological trigger. Videos of intermittent symptoms, when safely obtained and clinically requested, may sometimes assist assessment. People experiencing falls or episodes involving impaired awareness should seek individualized safety advice. Progress can include better mobility, fewer interruptions, improved school or work participation, and greater independence, even when some symptoms remain.
Frequently asked questions
What is the main cause of functional neurological disorder?
There is no single established cause for all FND. Current models examine altered brain-network functioning and interactions involving attention, expectations, sensory processing, motor control, arousal, and individual vulnerability. Studies also describe associations with medical events, psychiatric conditions, and adversity, but these do not establish one cause for every person. Current mechanistic review.
Can FND start without stress or trauma?
Yes. Neither trauma nor a specific stressor is required for diagnosis, and some patients report no identifiable precipitating event. The meta-analysis by Ludwig and colleagues explicitly documented that observation.
Can a physical injury or infection trigger FND?
A physical event can precede FND, including in clinical reports of functional movement symptoms. The timing alone does not prove that the event caused the later symptoms, and the original injury, infection, or another disorder may still need investigation or treatment. Physical-precipitant study.
Is FND caused by anxiety?
Anxiety may coexist with, contribute to, or follow FND, but an anxiety disorder is not required and cannot establish an FND diagnosis. Neurological findings and differential evaluation remain necessary. Clinical review.
Is FND a sign of hidden psychological trauma?
No. Trauma exposure is associated with FND in some studies, and individual causal explanations require specific clinical evidence. Clinicians should not infer undisclosed abuse or trauma solely from the presence of FND. Systematic review and meta-analysis.
Does a normal MRI mean someone has FND?
No. A normal MRI may help assess certain alternative conditions, but FND is diagnosed through recognized positive signs and appropriate clinical evaluation. Some patients have both FND and another neurological condition. Clinical review.
Are functional symptoms voluntary or deliberately produced?
FND symptoms are involuntary experiences. Changes across tasks or with attention can be positive clinical findings and do not demonstrate intentional deception. Assessment for factitious disorder or malingering involves separate evidence and cannot be inferred from apparent inconsistency. Clinical review.
Can FND and epilepsy occur together?
Yes. A person can experience epileptic seizures and functional seizures, requiring careful differentiation of episodes and appropriate treatment for each condition. AAN practice guideline.
Is FND inherited?
A simple hereditary cause and clinically validated genetic prediction test have not been established. Genetic and epigenetic vulnerabilities are subjects of developing research, and the findings do not permit individual prediction. Mechanisms review.
Can understanding a trigger cure FND?
Recognizing a relevant trigger may help build an individualized treatment plan, but identifying a definitive cause is not necessary for rehabilitation to begin. Care can address movement, functional episodes, coexisting conditions, and participation in daily life according to the clinical presentation. Practical management review.
Is FND permanent?
FND outcomes vary. Improvement is possible even when symptoms have been present for a long time, although chronicity may be linked to smaller gains in some outcomes. Individual prognosis requires assessment and follow-up rather than a rule based on time since onset alone. 2025 treatment-outcome meta-analysis.
Related Articles
For the historical distinction between conversion terminology and current diagnosis, read Conversion Neurosis: Historical Meaning and Functional Neurological Symptom Disorder. For how attention to bodily sensations relates to anxiety without treating anxiety as a universal FND cause, see Anxiety and Interoception: Why Body Sensations Can Become Threat Signals. For differential reading on seizure-like episodes, see Panic Attack vs Seizure: Symptoms, Awareness, and Medical Assessment.
References
American Academy of Neurology. (2026). Management of Functional Seizures Practice Guideline Executive Summary. Neurology, 106(1). https://doi.org/10.1212/WNL.0000000000214466.
American Psychiatric Association. (2022). Somatic Symptom and Related Disorders. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). https://doi.org/10.1176/appi.books.9780890425787.x09_Somatic_Symptom_and_Related_Disorders.
Aybek, S., & Perez, D. L. (2022). Diagnosis and management of functional neurological disorder. BMJ, 376, o64. https://doi.org/10.1136/bmj.o64.
Canadian Paediatric Society. (2024). Somatic symptom and related disorders: Guidance on assessment and management for paediatric health care providers. https://cps.ca/en/documents/position/somatic-symptom-and-related-disorders.
Dworetzky, B. A., & Baslet, G. (2025). Functional neurological disorder: Practical management. Neurotherapeutics, 22(4), e00612. https://doi.org/10.1016/j.neurot.2025.e00612.
Finkelstein, S. A., Diamond, C., Carson, A., & Stone, J. (2025). Incidence and prevalence of functional neurological disorder: A systematic review. Journal of Neurology, Neurosurgery & Psychiatry, 96, 383–395. https://doi.org/10.1136/jnnp-2024-334767.
Jungilligens, J., & Perez, D. L. (2025). Predictive Processing and the Pathophysiology of Functional Neurological Disorder. Current Topics in Behavioral Neurosciences, 74, 279–305. https://doi.org/10.1007/7854_2024_473.
Ludwig, L., et al. (2018). Stressful life events and maltreatment in conversion (functional neurological) disorder: Systematic review and meta-analysis of case-control studies. The Lancet Psychiatry, 5(4), 307–320. https://doi.org/10.1016/S2215-0366(18)30051-8.
Mavroudis, I., et al. (2025). Risk, Precipitating, and Perpetuating Factors in Functional Neurological Disorder: A Systematic Review Across Clinical Subtypes. Brain Sciences, 15(9), 907. https://doi.org/10.3390/brainsci15090907.
Millman, L. S. M., et al. (2025). Neurocognitive performance in functional neurological disorder: A systematic review and meta-analysis. European Journal of Neurology, 32(1), e16386. https://doi.org/10.1111/ene.16386.
Prudente, E., Savioz, V., Concetti, C., & Aybek, S. (2026). Mechanisms and Vulnerabilities in Functional Neurological Disorder. Seminars in Neurology, 46(2), 167–175. https://doi.org/10.1055/a-2772-7100.
Putica, A. (2026). Functional Neurological Disorder as a Disorder of Sensorimotor Inference Under Stress: A Neurocomputational Account. Biological Psychiatry Global Open Science. Advance online publication. https://doi.org/10.1016/j.bpsgos.2026.100825.
Sekine, E. R., et al. (2025). Biopsychosocial prognostic indicators in Functional Neurological Disorder: A systematic review. Journal of Psychosomatic Research, 195, 112201. https://doi.org/10.1016/j.jpsychores.2025.112201.
Thomas, S. T., et al. (2025). Treatment outcomes in functional neurological disorder: A systematic review and meta-analysis exploring the influence of symptom chronicity. BMJ Neurology Open, 7(2), e001150. https://neurologyopen.bmj.com/content/7/2/e001150.